New Phocoenamicin and Maklamicin Analogues from Cultures of Three Marine-Derived Micromonospora Strains
Authors:
- Maria KokkiniMaria Kokkini
- Daniel Oves-CostalesDODaniel Oves-Costales
- Pilar SánchezPSPilar Sánchez
- Ángeles MelguizoÁMÁngeles Melguizo
- Thomas A. MackenzieTMThomas A. Mackenzie
- Mercedes Pérez-BonillaMPMercedes Pérez-Bonilla
- Jesús MartínJMJesús Martín
- Arianna GiustiAGArianna Giusti
- Peter de WittePWPeter de Witte
- Francisca VicenteFVFrancisca Vicente
- Olga GenilloudOGOlga Genilloud
- Fernando ReyesFernando Reyes
Open Access
- 7 August 2023
- journal article
- research article
- Published by MDPI AG in Marine Drugs
- Vol. 21 (8) , 443
Abstract
Antimicrobial resistance can be considered a hidden global pandemic and research must be reinforced for the discovery of new antibiotics. The spirotetronate class of polyketides, with more than 100 bioactive compounds described to date, has recently grown with the discovery of phocoenamicins, compounds displaying different antibiotic activities. Three marine Micromonospora strains (CA-214671, CA-214658 and CA-218877), identified as phocoenamicins producers, were chosen to scale up their production and LC/HRMS analyses proved that EtOAc extracts from their culture broths produce several structurally related compounds not disclosed before. Herein, we report the production, isolation and structural elucidation of two new phocoenamicins, phocoenamicins D and E (1–2), along with the known phocoenamicin, phocoenamicins B and C (3–5), as well as maklamicin (7) and maklamicin B (6), the latter being reported for the first time as a natural product. All the isolated compounds were tested against various human pathogens and revealed diverse strong to negligible activity against methicillin-resistant Staphylococcus aureus, Mycobacterium tuberculosis H37Ra, Enterococcus faecium and Enterococcus faecalis. Their cell viability was also evaluated against the human liver adenocarcinoma cell line (Hep G2), demonstrating weak or no cytotoxicity. Lastly, the safety of the major compounds obtained, phocoenamicin (3), phocoenamicin B (4) and maklamicin (7), was tested against zebrafish eleuthero embryos and all of them displayed no toxicity up to a concentration of 25 μM.Keywords
Funding Information
- European Commission (721421, PCT-010000-2010-4, INP-2011-0016-PCT-010000 ACT6, PCT-01000-ACT7, 2011-13)
- Ministerio de Ciencia e Innovación (721421, PCT-010000-2010-4, INP-2011-0016-PCT-010000 ACT6, PCT-01000-ACT7, 2011-13)
This publication has 40 references indexed in Scilit:
- Balibalosides, an Original Family of Glucosylated Sesterterpenes Produced by the Mediterranean Sponge Oscarella balibaloiMarine Drugs, 2013
- Large-Scale Assessment of the Zebrafish Embryo as a Possible Predictive Model in Toxicity TestingPLOS ONE, 2011
- Maklamicin, an Antibacterial Polyketide from an Endophytic Micromonospora sp.Journal of Natural Products, 2011
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal ResearchPLOS Biology, 2010
- Elucidation of the Kijanimicin Gene Cluster: Insights into the Biosynthesis of Spirotetronate Antibiotics and NitrosugarsJournal of the American Chemical Society, 2007
- Natural products as a screening resourceCurrent Opinion in Chemical Biology, 2007
- Genetic Characterization of the Chlorothricin Gene Cluster as a Model for Spirotetronate Antibiotic BiosynthesisChemistry & Biology, 2006
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999
- Isolation, characterization and structures of PA-46101 A and B.The Journal of Antibiotics, 1990
- MM 46115, a new antiviral antibiotic from Actinomadura pelletieri. Characteristics of the producing cultures, fermentation, isolation, physico-chemical and biological properties.The Journal of Antibiotics, 1990